Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Finding the right no fee cash back card can enhance your savings. Discover which card suits your financial habits best.
26,735 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Anthropic stunned markets with a Series H that values the private AI firm near $1 trillion, signaling a new era for p...
Meta platforms just gave a crucial signal about AI-driven cloud demand. This piece breaks down why Nebius could stand...
When markets wobble, savvy investors turn to reliable income. Here are three excellent dividend stocks to buy on the ...
Oil markets react quickly to SPR chatter. This article explains what potential strategic petroleum releases could mea...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Chipotle stock topped market today as investors cheered a mix of global expansion news, digital growth, and improving...
Investors are weighing XRP and Dogecoin as potential additions to a volatile portfolio. This guide breaks down risk, ...
A sweeping housing proposal could unlock an easier path to ownership for many Americans. This guide breaks down what ...
As yields rise in early 2026, retirees are reallocating a $500,000 portfolio toward income-focused assets to secure s...
IonQ stands at the crossroads of hype and real-world adoption in quantum computing. This ionq stock analysis: sell pi...